Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Cancer Diagnostics Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the cancer diagnostics market has experienced a significant growth spurt. Its size is predicted to expand from $23.24 billion in 2024, to $25.73 billion in the following year, with a compound annual growth rate (CAGR) of 10.7%. The growth observed during the historical period is due to factors such as a rise in the number of cancer cases, cancer screening initiatives, the rise of personalized medication, and increased public awareness.

How Much Will the Cancer Diagnostics Market Be Worth in 2029?

The market for cancer diagnostics is anticipated to witness a swift expansion in the forthcoming years, reaching a market value of $40.82 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.2%. The prediction for such accelerated growth during the forecast period can be credited to factors such as the expansion of emerging markets, regulatory backing, the utilization of artificial intelligence (AI) and machine learning, and early detection initiatives. The forecast period also suggests significant trends like the use of liquid biopsies, multi-omics methods, point-of-care testing, and the proliferation of screening and early intervention campaigns.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

Which is the Largest Company in the Cancer Diagnostics Market?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

What Are the Main Market Drivers in the Cancer Diagnostics Industry?

The surge in different types of cancers is one of the primary reasons propelling the cancer diagnostics market. The reason being that the escalation in instances of different kinds of cancer cases results in an increased number of individuals seeking diagnosis and treatment. Moreover, the World Health Organization (WHO) has ranked cancer as the second main reason for deaths worldwide. Estimations from the National Cancer Institute (NCI) point to an expected rise in new cancer cases per year, projecting a total of 23.6 million by 2030.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

How Is the Cancer Diagnostics Market Segments Structured?

The cancer diagnostics market covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

What Strategic Trends Are Transforming the Cancer Diagnostics Market?

AI-based systems for detecting cancer are gaining traction in the field of cancer diagnostics. Through enhancing the precision of image recognition during diagnostic procedures such as for breast and lung cancers, AI supports early-stage cancer spotting. It also decreases the occurrence of false positives during lung cancer screening, thereby enhancing the detection accuracy. For example, a trustworthy solution comprising of cancer-detecting algorithms for the independent assessment of lymph node biopsies has been invented by the Naval Medical Center San Diego and Google’s AI research arm, Google AI. This AI intervention has amplified the accuracy of metastatic breast cancer detection to 99%.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

This Report Delivers Insight On:

1. How big is the cancer diagnostics market, and how is it changing globally?

2. Who are the major companies in the cancer diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the cancer diagnostics market right now?

4. Which products or customer segments are growing the most in the cancer diagnostics market?

5. What factors are helping or slowing down the growth of the cancer diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model